中国全科医学
中國全科醫學
중국전과의학
CHINESE GENERAL PRACTICE
2015年
23期
2870-2872
,共3页
心力衰竭%醛固酮受体拮抗剂%伊伐布雷定%左西孟旦%抗凝药%LCZ696%综述
心力衰竭%醛固酮受體拮抗劑%伊伐佈雷定%左西孟旦%抗凝藥%LCZ696%綜述
심력쇠갈%철고동수체길항제%이벌포뢰정%좌서맹단%항응약%LCZ696%종술
Heart failure%Aldosterone antagonists%Ivabradine%Levosimendan%Anticoagulants%LCZ696%Review
慢性心力衰竭是诸多心血管疾病的最后阶段,难以逆转,一直是医学界面临的重大难题。慢性心力衰竭的治疗由过去强调改善症状、提升生活质量转变为以防治和延缓心肌重构为主,降低病死率和再住院率。现根据心力衰竭治疗指南和大型研究结果,对治疗慢性心力衰竭的常规药物、新药和中药的研究进展进行综述。
慢性心力衰竭是諸多心血管疾病的最後階段,難以逆轉,一直是醫學界麵臨的重大難題。慢性心力衰竭的治療由過去彊調改善癥狀、提升生活質量轉變為以防治和延緩心肌重構為主,降低病死率和再住院率。現根據心力衰竭治療指南和大型研究結果,對治療慢性心力衰竭的常規藥物、新藥和中藥的研究進展進行綜述。
만성심력쇠갈시제다심혈관질병적최후계단,난이역전,일직시의학계면림적중대난제。만성심력쇠갈적치료유과거강조개선증상、제승생활질량전변위이방치화연완심기중구위주,강저병사솔화재주원솔。현근거심력쇠갈치료지남화대형연구결과,대치료만성심력쇠갈적상규약물、신약화중약적연구진전진행종술。
Chronic heart failure is the final phase of many cardiovascular diseases .It is difficult to reverse and has been the major problem facing the medicine filed .The focus of its treatment was changed from symptom remission and life quality improvement in the past into the deferring of myocardial remodeling , in order to reduce mortality and readmission rate .Based on guidelines and the results of large -scale researches , the study made a review of general drugs , new drugs and traditional Chinese medicine for chronic heart failure .